TNF and Insulin resistance: In this line, a recent study carried out by Bu and colleagues (2020) indicated that the inhibition of TNF-α release from activated macrophages relieved insulin resistance in skeletal muscle, concluding that TNF-α might become a therapeutic target to attenuate and control insulin resistance in obesity and type 2 diabetes [43].